We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Harmony Gold Mining
HMY
$12.3B
| $17.2M | 0.04% |
4,741,397
+933,143
| +25% | +$2.99M |
|
427
SLM Corp
SLM
$5.15B
| $17.2M | 0.04% |
1,926,799
-801,189
| -29% | -$6.96M |
|
|
EVRI
428
DELISTED
Everi Holdings
EVRI
| $17.1M | 0.04% |
1,275,145
+54,644
| +4% | +$623K |
|
429
Corcept Therapeutics
CORT
$12B
| $17.1M | 0.04% |
+1,412,627
| New | +$19.7M |
|
430
Genesco
GCO
$422M
| $17M | 0.04% |
355,077
+59,431
| +20% | +$2.47M |
|
431
PennyMac Financial
PFSI
$4.02B
| $17M | 0.04% |
498,348
+437,748
| +722% | +$14.2M |
|
432
Insight Enterprises
NSIT
$4.38B
| $16.9M | 0.04% |
241,098
-41,511
| -15% | -$2.62M |
|
433
Bain Capital Specialty
BCSF
$850M
| $16.9M | 0.04% |
873,264
+410,769
| +89% | +$7.73M |
|
434
PNC Financial Services
PNC
$101B
| $16.9M | 0.04% |
105,797
-1,101,382
| -91% | -$165M |
|
435
Zumiez
ZUMZ
$339M
| $16.9M | 0.04% |
488,738
+297,385
| +155% | +$9.4M |
|
|
INOV
436
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $16.9M | 0.04% |
896,728
+871,482
| +3,452% | +$14.6M |
|
437
BlackRock TCP Capital
TCPC
$345M
| $16.7M | 0.04% |
1,191,443
+250,446
| +27% | +$3.5M |
|
438
First Hawaiian
FHB
$3.35B
| $16.7M | 0.04% |
579,748
-301,406
| -34% | -$8.47M |
|
439
ABM Industries
ABM
$2.84B
| $16.7M | 0.04% |
441,753
-20,767
| -4% | -$775K |
|
440
Home Depot
HD
$355B
| $16.6M | 0.04% |
76,166
-1,124,612
| -94% | -$255M |
|
|
SWN
441
DELISTED
Southwestern Energy Company
SWN
| $16.6M | 0.04% |
6,872,440
+285,800
| +4% | +$591K |
|
442
Energy Transfer Partners
ET
$69.3B
| $16.6M | 0.04% |
1,295,216
+1,244,216
| +2,440% | +$15.3M |
|
443
Vishay Intertechnology
VSH
$5.43B
| $16.6M | 0.04% |
779,116
+729,216
| +1,461% | +$14.1M |
|
444
Emcor
EME
$36B
| $16.6M | 0.04% |
191,801
-111,633
| -37% | -$9.83M |
|
445
NETSCOUT
NTCT
$2.79B
| $16.5M | 0.04% |
686,528
+445,281
| +185% | +$10.5M |
|
|
LKFT
446
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
| $16.5M | 0.04% |
+79,694
| New | +$14.7M |
|
447
Minerals Technologies
MTX
$2.34B
| $16.4M | 0.04% |
285,355
+216,701
| +316% | +$11.7M |
|
448
Tanger
SKT
$4.52B
| $16.4M | 0.04% |
1,114,185
-57,787
| -5% | -$904K |
|
449
Visteon
VC
$2.78B
| $16.4M | 0.04% |
+189,478
| New | +$16.9M |
|
|
HTT
450
High Templar Tech Ltd
HTT
$391M
| $16.4M | 0.04% |
3,472,390
-313,705
| -8% | -$1.85M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.